REFEX270.90

Refex Industries Ltd.

· Chemicals
AnnualQuarterly₹ CrorePeersRCFRALLISRAINPRIVISCLSHARDACROPNFLSTYRENIXNEOGENMcap ₹3,717 Cr
View
In ₹ Crore except Per Share
12 Months Ending
Q2 FY24
30/09/2023
Q3 FY24
31/12/2023
Q4 FY24
31/03/2024
Q1 FY25
30/06/2024
Q2 FY25
30/09/2024
Q3 FY25
31/12/2024
Q4 FY25
31/03/2025
Q1 FY26
30/06/2025
Q2 FY26
30/09/2025
Q3 FY26
31/12/2025
Q4 FY26
31/03/2026
Q1 FY27
30/06/2026
Revenue from Operations352.2306.0342.3595.1527.7717.1627.8383.2426.9576.0934.2916.3
Other Income5.23.28.02.17.124.816.110.75.25.83.912.3
Total Income357.4309.2350.3597.2534.7741.9643.9393.9432.0581.8938.1928.7
Expenses
+ Cost of Materials Consumed52.363.594.181.568.3146.2247.7180.3179.2207.6758.2828.3
+ Purchases of Stock-in-Trade255.5198.9190.2466.1389.6494.6286.7158.8196.2276.60.00.0
+ Changes in Inventories2.0-1.60.1-15.410.92.12.3-16.2-36.3-18.2-5.7-52.7
+ Employee Benefit Expense5.25.46.18.58.110.012.714.010.99.97.710.8
+ Finance Costs6.28.38.55.85.47.78.89.96.69.110.112.9
+ Depreciation & Amortisation2.94.04.25.66.48.911.614.15.25.05.35.8
+ Other Expenses3.15.510.66.14.313.014.68.66.410.314.422.9
Total Expenses327.1284.0313.7558.2493.0682.6584.4369.5368.1500.4790.1828.1
EBITDA34.234.341.348.446.451.163.837.870.589.8159.5107.0
EBIT31.330.337.142.840.042.252.223.765.384.7154.2101.1
Profit
PBT before Exceptional Items30.325.236.639.141.759.359.524.463.981.4148.0100.5
+ Exceptional Items0.0-0.00.00.00.30.00.00.00.00.00.00.0
Pretax Income30.325.236.639.142.059.359.524.463.981.4148.0100.5
+ Current Tax7.37.18.412.111.810.215.78.019.221.937.225.8
+ Deferred Tax1.61.2-5.2-2.4-0.9-0.9-4.1-4.1-0.6-1.84.80.2
Tax Expense8.98.33.29.711.09.311.63.918.620.042.026.0
+ Share of Associates & JVs0.0-0.00.00.00.00.00.00.00.00.00.00.0
Net Income21.416.933.429.331.150.147.920.436.252.794.464.6
+ Net Income — Continuing Ops21.416.933.429.331.150.147.920.545.361.3106.074.5
+ Net Income — Discontinued Ops0.00.00.00.00.00.00.0-0.2-9.1-8.6-11.5-10.0
+ Other Comprehensive Income-0.1-0.10.00.00.0-0.0-1.5-0.45.60.55.8-7.9
Total Comprehensive Income21.316.833.429.331.150.046.519.941.853.2100.256.6
Net Income to Common34.330.031.150.148.321.237.453.990.863.8
Minority Interest-0.9-0.70.0-0.4-0.8-1.3-1.23.60.8
Per Share
Basic EPS9.707.643.022.542.603.993.711.582.803.946.624.65
Diluted EPS9.647.623.002.502.583.863.521.502.663.896.544.59
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax0.00.00.00.00.00.00.0-0.2-12.4-11.9-15.7-13.9
+ Tax — Discontinued Operations0.00.00.00.00.00.00.0-0.1-3.3-3.3-4.2-4.0
Other Comprehensive Income — detail
+ Other Comprehensive Income-1.5-0.45.60.55.8-7.9
+ Items NOT to be Reclassified to P&L0.0-0.00.05.61.1
+ Items to be Reclassified to P&L-1.9-0.40.54.6-7.9
+ Tax on Items to be Reclassified-0.50.00.00.00.00.0
Comprehensive Income — Owners of Parent0.00.034.330.031.150.047.121.141.654.295.758.0
Comprehensive Income — Non-controlling Interests0.00.0-0.9-0.70.00.0-0.7-1.10.2-1.04.5-1.4
Per Share — as-filed variants
Basic EPS — Continuing Operations9.707.643.022.542.603.993.711.593.504.577.465.38
Diluted EPS — Continuing Operations9.647.623.002.502.583.863.521.513.364.527.385.32
Basic EPS — Discontinued Operations0.000.000.000.000.000.000.00-0.01-0.70-0.63-0.84-0.73
Diluted EPS — Discontinued Operations0.000.000.000.000.000.000.00-0.01-0.70-0.63-0.84-0.73
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit42.445.258.063.058.974.291.160.487.8109.9181.7140.7
Gross Margin %12.0314.7916.9310.5811.1510.3414.5115.7720.5719.0819.4515.35
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)30.325.236.639.141.759.359.524.463.981.4148.0100.5
− Exceptional Items (reconciliation)0.0-0.00.00.00.30.00.00.00.00.00.00.0
Net Income Adj (tax-effected)21.416.933.429.330.950.147.920.436.252.794.464.6
EPS Adj9.697.643.022.542.583.993.711.582.803.946.624.65
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.002.002.002.002.002.002.002.002.002.002.00
Paid Up Equity Capital22.122.123.123.124.125.825.825.925.927.427.427.4
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.